These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1081755)

  • 1. Proceedings: Mechanisms of the prolonged bleeding time in von Willebrand's disease (vWd).
    Mannucci PM; Holmberg L; Ruggeri ZM; Nilsson IM
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607. PubMed ID: 1081755
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Transfusion and gel filtration studies in von Willebrand's disease.
    Kernoff PB; Rizza CR; Kaelin AC
    Br J Haematol; 1974 Jun; 27(2):364. PubMed ID: 4546378
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bleeding disease (von Willebrand's disease) in a Chesapeake Bay Retriever.
    Johnson GS; Lees GE; Benson RE; Rosborough TK; Dodds WJ
    J Am Vet Med Assoc; 1980 Jun; 176(11):1261-3. PubMed ID: 6776082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Abnormal factor VIII in von Willebrand's disease.
    Thompson C; Forbes CD; Prentice CR
    Br J Haematol; 1974 Sep; 28(1):144. PubMed ID: 4547281
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of heat-treated factor VIII concentrates in von Willebrand's disease and related disorders: studies in platelet-type von Willebrand's disease].
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Takizawa S; Tamura M; Yamaguchi T; Wada K; Shibata A
    Rinsho Ketsueki; 1987 Dec; 28(12):2117-24. PubMed ID: 3133507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
    Guimbretére J
    Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
    [No Abstract]   [Full Text] [Related]  

  • 10. Von Willebrand's disease with thrombocytopenia, platelet function defect, and an abnormal Factor VIII molecule.
    Arkel YS; Desposito F
    Am J Pediatr Hematol Oncol; 1982; 4(3):249-57. PubMed ID: 6816083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: An abnormality of factor-VIII-related protein (FVIIIRP)--possible variants of von Willebrand's disease.
    Peake IR; Giddings JC; Bloom AL
    Br J Haematol; 1974 Sep; 28(1):143-4. PubMed ID: 4547282
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Willebrand's disease: current concepts and report of case.
    Lorson EL; Goldwasser MS; Osbon DB; Kirby RW
    J Oral Surg; 1976 Jul; 34(7):655-60. PubMed ID: 1084416
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia.
    Rahmani R; Rozen P; Papo J; Iellin A; Seligsohn U
    Isr J Med Sci; 1990 Sep; 26(9):504-9. PubMed ID: 2121664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables.
    Wahlberg TB; Blombäck M; Ruggeri ZM
    Thromb Haemost; 1983 Dec; 50(4):864-8. PubMed ID: 6420925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clues to the pathogenesis of bleeding in von Willebrand's disease.
    Ratnoff OD; Bennett B
    N Engl J Med; 1973 Nov; 289(22):1182-3. PubMed ID: 4543184
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
    Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
    Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variant of von Willebrand's disease in 3 Polish families].
    Pniejnia-Olszyński W; Bykowska K; Lopaciuk S
    Acta Haematol Pol; 1980; 11(3):201-9. PubMed ID: 6778054
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic problems of von Willebrand's disease in a general hospital laboratory.
    Dahl CJ; McRoyan DK; Liu PI
    Ann Clin Lab Sci; 1983; 13(5):371-8. PubMed ID: 6416137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIII in von Willebrand's disease.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):165-72. PubMed ID: 6797214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.